Pre-hospital glycemia as a biomarker for in-hospital all-cause mortality in diabetic patients - a pilot study

• Published in: Cardiovascular diabetology Vol. 23; no. 1; pp. 153 - 17
• Main Authors: Greco, Salvatore, Salatiello, Alessandro, De Motoli, Francesco, Giovine, Antonio, Veronese, Martina, Cupido, Maria Grazia, Pedarzani, Emma, Valpiani, Giorgia, Passaro, Angelina
• Format: Journal Article
• Language: English
• Published: England BioMed Central 03.05.2024; BMC
• Subjects: AdaBoost-FAS; Aged; Antidiabetics; Biomarkers; Biomarkers - blood; Blood glucose; Blood Glucose - metabolism; Blood levels; Cause of Death; Clinical outcomes; Comorbidity; Diabetes; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2 - blood; Diabetes Mellitus, Type 2 - diagnosis; Diabetes Mellitus, Type 2 - mortality; Expenditures; Female; Glucose; Glucose metabolism disorder; Glycemic Control - mortality; Glycemic index; Glycemic variability; Health risks; Hospital Mortality; Hospitalization; Hospitals; Humans; Hyperglycemia; Hypoglycemia; Insulin; Learning algorithms; Machine Learning; Male; Metabolism; Middle Aged; Mortality; Observational studies; Patient admissions; Patients; Pilot Projects; Predictive Value of Tests; Prognosis; Risk Assessment; Risk Factors; Statistical analysis; Statistics; Time Factors; Type 2 diabetes mellitus; United States > US; Italy; Glucose metabolism disorder; Type 2 diabetes mellitus; AdaBoost-FAS; Glycemic variability; Machine learning

Type 2 Diabetes Mellitus (T2DM) presents a significant healthcare challenge, with considerable economic ramifications. While blood glucose management and long-term metabolic target setting for home care and outpatient treatment follow established procedures, the approach for short-term targets durin...